Tag: Stada

Stada Arzneimittel AG is a pharmaceutical company based in Bad Vilbel, Germany which specializes in the production of generic and over-the-counter drugs.

EMA accepted the resubmission for review of Neulasta biosimilar

STADA Arzneimittel AG was informed by Gedeon Richter Plc. that the European Medicines Agency (EMA) has accepted the regulatory resubmission of its proposed biosimilar to Amgen's Neulasta (pegfilgrastim).

Russian pharma companies are registering medicines in more than 60 countries

When Pharma-2020 was launched in 2010, its first priority was to provide domestically manufactured medicines

Yellow fever vaccine is the top Russian export product

In January - October, 2017, the Russian exports of medicinal products (excluding exports to EAEU) amounted to 16.7 billion rubles (including customs duties)

Hemofarm expands its line of drugs labeled under a pilot project

LLC Hemofarm has released a batch of Tagista, medication for treatment of vertigo and headache, marked with unique DataMatrix identification codes on each package

Enzymatica got the largest order from STADA

Enzymatica, a Swedish life science company, has received its largest order to date for a total of about SEK 12 million

Stada accepts €5.3 billion offer from Bain Capital and Cinven

Stada Arzneimittel announced Monday that it agreed to sell itself to private-equity firms Bain Capital and Cinven for 5.3 billion euros ($5.6 billion) having determined that the bid was "the most fina...

STADA products are now distributed through Russian FMCG chains

STADA products have become available among the fast moving consumer goods in retail chains and retail stores. For example, in Auchan stores, it is already possible to buy Aqualor, a product for preven...

Stada recieves a $3.7 billion offer

German company announced that Boston private equity outfit Advent International had put up a legally binding bid of €58 per share in cash, plus a 2016 dividend payment; in 2015, that payment amounted ...

STADA confirms receipt of non-binding expressions of interest in takeover bid

Due to market rumours, STADA Arzneimittel AG confirms that it has received two legally non-binding expressions of interest regarding a bid for the acquisition of up to 100 percent of the shares in the...